(Total Views: 91)
Posted On: 12/12/2017 10:43:20 AM
Post# of 89358
Re: antoniorosset #75130
$STLT 's brand new first ever product, based on Cobra snake venom currently in Cancer drug trials, now being sold as a rub on pain killer to help solve the opioid crisis, quietly hit WALMART store shelves and online as VENODOL at Drug store chains and at Walmart this weekend. They also hired a a firm to do a massive ad campaign. They reported 250,000 of inventory in the recent 10-Q, now we know where it went!
Way over sold biotech here, still at 10% of its 2016 highs. Super low OS, about 38 Mil, about 8 Mil shares in the float and the officers own about 60% of the issued shares. This is a real biotech with cancer drug trials, that just hit the revenue stage to make $$$$$$$$$$$$$$$$
This is huge, and it rallies easy, floats on air. Does not take much buying to make it run hard!!! Less than 200,000 share buying rallied it 85 Last week on Friday.
Way over sold biotech here, still at 10% of its 2016 highs. Super low OS, about 38 Mil, about 8 Mil shares in the float and the officers own about 60% of the issued shares. This is a real biotech with cancer drug trials, that just hit the revenue stage to make $$$$$$$$$$$$$$$$
This is huge, and it rallies easy, floats on air. Does not take much buying to make it run hard!!! Less than 200,000 share buying rallied it 85 Last week on Friday.
(0)
(0)
